IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,500 | -35.2% | 92,537 | +0.1% | 0.00% | – |
| Q2 2023 | $650,384 | +102.4% | 92,449 | +75.7% | 0.00% | – |
| Q1 2023 | $321,299 | +109.3% | 52,628 | +118.9% | 0.00% | – |
| Q4 2022 | $153,526 | -33.6% | 24,044 | -50.0% | 0.00% | – |
| Q3 2022 | $231,231 | -12.7% | 48,090 | +99.8% | 0.00% | – |
| Q2 2022 | $265,000 | -33.6% | 24,069 | +0.3% | 0.00% | – |
| Q1 2022 | $399,000 | -12.9% | 24,001 | +0.1% | 0.00% | – |
| Q4 2021 | $458,000 | -81.5% | 23,985 | -69.3% | 0.00% | -100.0% |
| Q1 2021 | $2,476,000 | +196.9% | 78,211 | +334.4% | 0.00% | – |
| Q4 2020 | $834,000 | – | 18,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |